Probiotics for infantile colic: a randomized, double-blind, placebo-controlled trial investigating Lactobacillus reuteri DSM 17938.

Study answer

What this study found

Lactobacillus reuteri DSM 17938 reduced crying and fussing more than placebo and was well tolerated. By day 21, median daily crying and fussing time was 60 minutes in the probiotic group, and the total crying/fuss time over 21 days was 1719 ± 750 minutes versus 2195 ± 764 minutes in placebo. The day 21 responder rate was 17 of 24 with L. reuteri versus 6 of 28 with placebo (P = .035), and the relative risk for a at least 50% reduction was 3.3 (95% CI, 1.55-7.03). No adverse events were reported in either group.

Study & population

Randomized, double-blind, placebo-controlled trial in exclusively breastfed infants with infantile colic in Toronto, Ontario, Canada.

Intervention

Lactobacillus reuteri DSM 17938 was given as 1 x 10^8 CFU in 5 drops of freeze-dried oral solution suspended in sunflower oil, medium-chain triglyceride oil, and silicon dioxide.

Key limitation

The trial was small, with only 24 analyzed infants in the active arm, which limits precision.

View full study detailsView sourceOpen PDF

Original abstract